(Q49164116)

21 June 2018

title

Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer. (English)

1 reference

21 June 2018

1 reference

H Naitoh

1

1 reference

21 June 2018

Y Eguchi

2

1 reference

21 June 2018

H Ueyama

3

1 reference

21 June 2018

M Kodama

4

1 reference

21 June 2018

T Hattori

5

1 reference

21 June 2018

publication date

1 January 1995

1 reference

21 June 2018

number of pages

9

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

21 June 2018

volume

86

1 reference

21 June 2018

issue

1

1 reference

21 June 2018

page(s)

48-56

1 reference

21 June 2018

Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

The human urokinase-plasminogen activator gene and its promoter.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Plasminogen activators, tissue degradation, and cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Proteolytic degradation of extracellular matrix in tumor invasion

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Recent developments in the cell biology of basic fibroblast growth factor

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Non-radioactive detection of nerve growth factor receptor (NGFR) mRNA in rat brain using in situ hybridization histochemistry

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Type-1 plasminogen activator inhibitor in human breast carcinomas

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Enzymatic properties of the phosphorylated urokinase-type plasminogen activator isolated from a human carcinomatous cell line

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Phosphorylation of a surface receptor bound urokinase-type plasminogen activator in a human metastatic carcinomatous cell line

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920580

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines

22 June 2018

1 reference

12 December 2020

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

1 reference

12 December 2020

Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen

1 reference

12 December 2020

Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors

1 reference

12 December 2020

Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors

1 reference

12 December 2020

Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification

1 reference

12 December 2020

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1 reference

12 December 2020

Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C

1 reference

12 December 2020

Nonradioactive labeling of probe with digoxigenin by polymerase chain reaction

1 reference

12 December 2020

Plasminogen activator inhibitors in endometrial adenocarcinoma

1 reference

12 December 2020

Plasminogen activator system in human breast cancer

1 reference

12 December 2020

Localization of plasminogen activators in human colon cancer by immunoperoxidase staining

1 reference

12 December 2020

Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme

1 reference

12 December 2020

10.1111/J.1349-7006.1995.TB02987.X

Identifiers

DOI

1 reference

21 June 2018

PMC publication ID

5920580

1 reference

21 June 2018

PubMed publication ID

7737909

1 reference

21 June 2018